Table 1.
Group | Number of rat | Alveolar hyperplasia | Alveolar atypical dysplasia | ||
n | Incidence (%) | n | Incidence (%) [Decreasea] | ||
A. Aspirin | 10 | 6 | 60.00 | 1 | 10.00◆ [84.00%] |
B. PEITC | 10 | 4 | 40.00 | 1 | 10.00◆ [84.00%] |
C. Aspirin + PEITC | 10 | 1 | 10.00 | 0 | 0.00◆◆ [100.00%] |
D. Positive control | 8 | 2 | 25.00* | 5 | 62.50** |
E. Negative control | 9 | 0 | 0 | 0 | 0 |
a Compared with the incidence of alveolar atypical dysplasia in group D
*p < 0.05 when compared with negative control group by Fisher's exact probability test.
**p < 0.01 when compared with negative control group by Fisher's exact probability test.
◆p < 0.05 when compared with positive control group by Fisher's exact probability test.
◆◆p < 0.01 when compared with positive control group by Fisher's exact probability test.